Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$81,833,043
+$56,979,322 QoQ
Shares Held
1,440,469
+72.2% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#22
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. TVTX ranks #17 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in TVTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,833,043 | 1,440,469 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,853,721 | 836,544 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $41,822,983 | 1,094,556 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,851,722 | 663,252 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $16,735,099 | 1,130,750 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $30,707,568 | 1,713,592 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $39,689,292 | 2,278,375 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $25,742,565 | 1,840,069 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $12,601,850 | 1,533,072 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,222,351 | 1,844,663 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $14,906,740 | 1,658,147 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,792,891 | 983,545 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $19,369,020 | 1,261,004 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $22,478,551 | 999,491 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,817,644 | 466,840 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,260,771 | 375,843 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,390,477 | 428,827 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $12,251,083 | 475,401 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,781,464 | 347,341 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,841,546 | 405,837 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,475,872 | 1,197,798 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $36,867,680 | 1,476,479 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $42,077,412 | 1,543,842 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 RTRX | — | 1,653,038 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 RTRX | — | 1,783,132 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 RTRX | — | 1,586,531 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||